Tvardi Therapeutics (TVRD) FCF Margin (2013 - 2025)
Tvardi Therapeutics' FCF Margin was -299.30% in Q1 2025, up 1166.23 percentage points from -1465.53% a year earlier and up 32.87 percentage points from the prior quarter.
Powered by 
Analysis
Tvardi Therapeutics (TVRD) FCF Margin (2013 - 2025) Analysis & Trends
On a trailing twelve-month basis, Tvardi Therapeutics' FCF Margin was 56.12% through Mar 31, 2025, up 592.20 percentage points year-over-year; for FY2024, it was -271.14%, up 179.33 percentage points from FY2023.
- FCF Margin shows a five-year change of +278.21 percentage points (FY2019 to FY2024).
- In earlier years, FCF Margin was -450.46% in FY2023 (-262.31 pp), -188.15% in FY2022 (+72.95 pp), -261.10% in FY2021 (-256.78 pp) and -4.32% in FY2020 (+545.03 pp).
- Quarterly FCF Margin has moved between -1465.53% (Q1 2024) and 2363.87% (Q2 2024) over five years.
- Compared with a year earlier, FCF Margin has increased for four straight quarters, with an average year-over-year change of +375.88 percentage points over the last eight quarters.
- The best year-over-year quarter for FCF Margin over five years was Q2 2024 (a gain of 2658.77 percentage points); the worst was Q1 2024 (a drop of 904.00 percentage points).
- Per Business Quant data, TVRD's FCF Margin in the three quarters before Q1 2025 was -332.16% (Q4 2024), -260.37% (Q3 2024) and 2363.87% (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.17 Bn | 1,102.76 Bn | 19.71 Bn | 33.76% |
| 2 | Johnson & Johnson | 615.84 Bn | 534.36 Bn | 17.26 Bn | 28.82% |
| 3 | AbbVie | 500.69 Bn | 473.80 Bn | 12.70 Bn | 18.33% |
| 4 | Merck | 367.34 Bn | 321.72 Bn | 12.21 Bn | 26.96% |
| 5 | Novartis Ag | 297.61 Bn | 261.60 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 261.07 Bn | 234.75 Bn | 12.86 Bn | 6.55% |
| 7 | Amgen | 235.51 Bn | 190.91 Bn | 7.24 Bn | 34.70% |
| 8 | Gilead Sciences | 190.60 Bn | 164.80 Bn | 6.22 Bn | 44.00% |
| 9 | Pfizer | 169.37 Bn | 116.02 Bn | 10.94 Bn | 2.01% |
| 10 | Tvardi Therapeutics | 9.99 Mn | -98.11 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -299.30% |
| Dec 31, 2024 | -332.16% |
| Sep 30, 2024 | -260.37% |
| Jun 30, 2024 | 2,363.87% |
| Mar 31, 2024 | -1,465.53% |
| Dec 31, 2023 | -646.54% |
| Sep 30, 2023 | -403.72% |
| Jun 30, 2023 | -294.89% |
| Mar 31, 2023 | -561.52% |
| Dec 31, 2022 | -720.94% |
| Sep 30, 2022 | -232.98% |
| Jun 30, 2022 | -19.58% |
| Mar 31, 2022 | -533.78% |
| Dec 31, 2021 | -151.64% |
| Sep 30, 2021 | -69.63% |
| Mar 31, 2021 | -1,225.89% |
| Dec 31, 2020 | 73.09% |
| Sep 30, 2020 | -233.33% |
| Jun 30, 2020 | -490.81% |
| Mar 31, 2020 | -473.29% |
API Access
Tvardi Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=TVRD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "TVRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=TVRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();